Harmony Biosciences Holdings, Inc. - 8-K Filing
Harmony Biosciences announces Q2 revenue, CFO departure, and interim financial officer appointment (Items: 2.02 Results of Operations and Financial Condition, 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $HRMY